Skip to main content
Top
Published in: Inflammopharmacology 6/2020

Open Access 01-12-2020 | Ulcerative Colitis | Original Article

Paeoniflorin ameliorates ulcerative colitis by modulating the dendritic cell-mediated TH17/Treg balance

Authors: Kai Zheng, Jia Jia, Shihai Yan, Hong Shen, Ping Zhu, Jiangyi Yu

Published in: Inflammopharmacology | Issue 6/2020

Login to get access

Abstract

Immunological tolerance is critical for maintaining gut homeostasis. An imbalance between interleukin-17 (IL-17)-producing T helper 17 (TH17) cells and regulatory T cells (Treg cells) is involved in ulcerative colitis (UC) pathogenesis. Dendritic cells (DCs) are able to induce T cell differentiation. Paeoniflorin (PF) is a monoterpene glucoside that is commonly used for treatment of autoimmune disease. However, the immunological mechanism of PF involvement in UC treatment is unclear. The present study aimed to explore whether PF can restore the TH17/Treg balance by modulating DCs. The effects of PF on DCs, TH17 cells and Treg cells were measured. Furthermore, PF-treated DCs were injected into mice with 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. PF inhibited MHC-II and CD86 expression on the DC surface (P < 0.05), decreased interleukin (IL)-12 secretion in vitro and in vivo (P < 0.05), and restored the TH17/Treg ratio in the mouse model of colitis (P < 0.05). PF-treated DCs diminished TH17 differentiation (4.26% in vitro and 1.64% in vivo) and decreased IL-17 expression (P < 0.05) while inducing CD4+CD25+Foxp3+ Treg differentiation (7.82% in vitro and 6.85% in vivo) and increasing Foxp3 and IL-10 production (P < 0.05). Additionally, both PF and PF-treated DCs improved colonic histopathology in the mouse model of colitis (P < 0.05). In conclusion this study suggested that PF can ameliorate TNBS-induced colitis by modulating the DC-mediated TH17/Treg balance.
Literature
go back to reference Kirsner JB (2001) Origins and directions of inflammatory bowel disease. Springer, NetherlandsCrossRef Kirsner JB (2001) Origins and directions of inflammatory bowel disease. Springer, NetherlandsCrossRef
Metadata
Title
Paeoniflorin ameliorates ulcerative colitis by modulating the dendritic cell-mediated TH17/Treg balance
Authors
Kai Zheng
Jia Jia
Shihai Yan
Hong Shen
Ping Zhu
Jiangyi Yu
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Inflammopharmacology / Issue 6/2020
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-020-00722-6

Other articles of this Issue 6/2020

Inflammopharmacology 6/2020 Go to the issue